Spinal muscular atrophy (SMA) is a devastating autosomal recessive neuromuscular disorder characterized by the degeneration of spinal motor neurons, leading to progressive muscle weakness and atrophy. It is the leading genetic cause of infant mortality and affects approximately 1 in 10,000 live births[1].
| Property | Value |
|---|---|
| Category | Motor Neurons |
| Location | Anterior horn of spinal cord (ventral horn) |
| Cell Type | Alpha motor neurons |
| Key Gene | SMN1 (Survival Motor Neuron 1) |
| Inheritance | Autosomal recessive |
| Incidence | 1:10,000 live births |
The SMN (Survival Motor Neuron) protein is encoded by the SMN1 gene and is essential for:
The degeneration of spinal motor neurons in SMA involves:
| Defect | Consequence |
|---|---|
| Reduced snRNP assembly | Global splicing deficits |
| Mis-splicing of critical genes | Dysregulation of neuronal genes |
| Impaired axonal RNA transport | Local translation defects |
| Type | Age of Onset | Severity | Motor Milestones |
|---|---|---|---|
| Type 1 (Werdnig-Hoffmann) | 0-6 months | Severe | Never sits |
| Type 2 (Dubowitz) | 6-18 months | Intermediate | Sits, doesn't walk |
| Type 3 (Kugelberg-Welander) | >18 months | Mild | Walks, loses ability |
| Type 4 | Adult | Very mild | Normal, mild weakness |
| Treatment | Mechanism | Approval |
|---|---|---|
| Zolgensma (onasemnogene abeparvovec) | AAV9-SMN1 | 2019 (FDA) |
| Spinraza (nusinersen) | ASO to promote SMN2 exon 7 inclusion | 2016 (FDA) |
| Evrysdi (risdiplam) | Small molecule SMN2 splicing modifier | 2020 (FDA) |
SMN protein levels - In blood and CSF
Phosphorylated neurofilament - Neurodegeneration marker
Motor unit number estimation (MUNE) - Functional assessment
The study of Spinal Motor Neurons In Spinal Muscular Atrophy has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Lefebvre et al. [(1995). Identification and characterization of the spinal muscular atrophy gene. Cell, 80(1), 155-165](https://doi.org/10.1016/0092-8674(95). 1995. ↩︎